Novo Nordisk Pharmaceutical Industries LP
FDA inspection history in Durham, North Carolina, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Durham, North Carolina.
Cited most
Across all Novo Nordisk Pharmaceutical Industries observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.111Time limitations on production1
- 21 CFR 211.166Stability testing1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.46Ventilation, air filtration, air heating and cooling1
The complete Novo Nordisk Pharmaceutical Industries file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Durham, North Carolina
One Form 483 · 2024 · 6 observations
Latest: Form 483, Aug 29, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-08-29 | 483 Form 483 | Durham, North Carolina | 6 | $99 |
Investigators on these documents
FEI number 3016799712 · most recent document Aug 29, 2024
About Novo Nordisk Pharmaceutical Industries LP
How many FDA Form 483s has Novo Nordisk Pharmaceutical Industries LP received?
FDA Intel has 1 Form 483 on file for Novo Nordisk Pharmaceutical Industries LP; the most recent is dated Aug 29, 2024.
When was Novo Nordisk Pharmaceutical Industries LP last inspected by FDA?
The most recent FDA inspection document on file for Novo Nordisk Pharmaceutical Industries LP is a Form 483 dated Aug 29, 2024, for the site in Durham, North Carolina.
What did FDA cite at Novo Nordisk Pharmaceutical Industries LP?
The regulations cited most in the observations on file for Novo Nordisk Pharmaceutical Industries LP are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.111 (Time limitations on production), 1 time; 21 CFR 211.166 (Stability testing), 1 time.